1Department of Anesthesia, Huntington Memorial Hospital, Pasadena, CA;
2Gold Coast Research, LLC, Weston, FL;
3Department of Orthopedic Surgery, Andrews Sports Medicine and Orthopedic Center, Birmingham, AL;
4Department of Anesthesiology, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, NJ;
5Arizona Research Center, Phoenix, AZ;
6Department of Anesthesiology, David Geffen School of Medicine, Ronald Reagan UCLA Medical Center, Los Angeles, CA;
7AcelRx Pharmaceuticals, Inc, Redwood City, CA;
8Bavarian Nordic, Mountain View, CA; and
9Department of Anesthesiology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA.
Address for correspondence: Founder & Chief Scientific Officer, Lotus Clinical Research LLC, 100 W California Boulevard, Pasadena, CA 91105. E-mail: [email protected]
Presented as a poster at the 24th Annual Meeting of the American Academy of Pain Medicine, 2008, Orlando, FL (Viscusi ER, Royal MA, Leclerc A, Fong L, Breitmeyer J. Pharmacokinetics, efficacy and safety of IV acetaminophen in the treatment of pain following total hip arthroplasty: results of a double-blind, randomized, placebo-controlled, single-dose study). Also presented at 24th Annual Meeting of the American Academy of Pain Management, February 12–16, 2008, Orlando, FL (Gimbel J, Royal MA, Leclerc A, Smith H, Breitmeyer J. Efficacy and safety of IV acetaminophen in the treatment of pain following primary total hip arthroplasty: results of a double-blind, randomized, placebo-controlled, multiple-dose, 24 hour study).
N. K. Singla is a consultant for and on the speaker's bureau for Cadence Pharmaceuticals, Inc. (Cadence), and has received research support from Cadence. M. E. Hale is a clinical trial principal investigator for Cadence. J. Gimbel is a clinical trial principal investigator for Cadence. J. Jahr is on the speaker's bureau for Cadence and is a principal investigator on 2 UPSA and 2 BMS studies of IV acetaminophen. M. A. Royal is a former employee of Cadence. R. Y. Ang is a former employee of Cadence. E. R. Viscusi is a clinical trial principal investigator and on the speaker's bureau for Cadence. E. R. Viscusi received payment for lectures including service on speakers bureaus from Cadence, AcelRx, Salix, Cubist, Pacira. For the remaining authors, none were declared. These studies were funded by Bristol-Myers Squibb (New York, NY).
